Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V V Row

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1981
Suppressor T lymphocyte dysfunction in Graves' disease: role of the H-2 histamine receptor-bearing suppressor T lymphocytesN Okita, J How, D Topliss, et al.
Acta Endocrinologica|February 1, 1973
The effect of alteration of thyroxine binding capacity on the dialyzable and absolute fractions of triiodothyronine in circulationJ H Dussault, D A Fisher, J T Nicoloff, et al.
Clinical Endocrinology|January 1, 1983
T lymphocyte sensitization and suppressor T lymphocyte defect in patients long after treatment for Graves' diseaseJ How, D J Topliss, C Strakosch, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 1, 1987
The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidismH C Gerstein, B Rastogi, Y Iwatani, et al.
Journal of Endocrinological Investigation|February 1, 1984
Biological activity of lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditisW Pruzanski, H Capes, R Baur, et al.
Journal of Endocrinological Investigation|December 1, 1986
Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity testM Iitaka, J Bernstein, H C Gerstein, et al.
Autoimmunity|January 1, 1989
Lack of effect of methimazole on thyrocyte cell-surface antigen expressionJ Aguayo, P Michaud, M Iitaka, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1981
Suppressor T lymphocyte dysfunction in Graves' disease: role of the H-2 histamine receptor-bearing suppressor T lymphocytesN Okita, J How, D Topliss, et al.
Acta Endocrinologica|February 1, 1973
The effect of alteration of thyroxine binding capacity on the dialyzable and absolute fractions of triiodothyronine in circulationJ H Dussault, D A Fisher, J T Nicoloff, et al.
Clinical Endocrinology|January 1, 1983
T lymphocyte sensitization and suppressor T lymphocyte defect in patients long after treatment for Graves' diseaseJ How, D J Topliss, C Strakosch, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 1, 1987
The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidismH C Gerstein, B Rastogi, Y Iwatani, et al.
Journal of Endocrinological Investigation|February 1, 1984
Biological activity of lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditisW Pruzanski, H Capes, R Baur, et al.
Journal of Endocrinological Investigation|December 1, 1986
Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity testM Iitaka, J Bernstein, H C Gerstein, et al.
Autoimmunity|January 1, 1989
Lack of effect of methimazole on thyrocyte cell-surface antigen expressionJ Aguayo, P Michaud, M Iitaka, et al.
Pageof 7